Skip to main content
OpenTrials

Clinical trial condition

Short Bowel Syndrome

Explore clinical trials studying Short Bowel Syndrome. Study availability and eligibility vary by location and protocol.

95 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Short Bowel Syndrome trial results

Completed

Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)

NCT00930644

Conditions
Digestive System Diseases, Gastrointestinal Diseases, Hyperphagia, +8 more
Locations
  • Scripps Clinic & Research Foundation La Jolla, California, United States
  • Mount Sinai Medical Center New York, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
  • University of Pennslyvania Philadelphia, Pennsylvania, United States
View all 23 locations
View Trial Details
Completed

A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021

NCT01560403

Conditions
Digestive System Diseases, Gastrointestinal Diseases, Hyperphagia, +8 more
Locations
  • Scripps Clinic & Research Foundation La Jolla, California, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
  • Mount Sinai Medical Center New York, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition

NCT02682381

Conditions
Digestive System Diseases, Gastrointestinal Diseases, Hyperphagia, +8 more
Locations
  • Children's Hospital Los Angeles - RHU Los Angeles, California, United States
  • UCLA Dept. of Medicine Los Angeles, California, United States
  • UCSF Benioff Children's Hospital San Francisco, California, United States
  • Georgetown Children's Research Network Washington D.C., District of Columbia, United States
View all 27 locations
View Trial Details
Completed

A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome

NCT01952080

Conditions
Digestive System Diseases, Gastrointestinal Diseases, Intestinal Diseases, +5 more
Locations
  • Children´s Hospital of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Mattel Children's Hospital UCLA, Department of Pediatric Gastroenterology Los Angeles, California, United States
View all 19 locations
View Trial Details
Completed

Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome (SBS)

NCT02340819

Conditions
Digestive System Diseases, Gastrointestinal Diseases, Intestinal Diseases, +5 more
Locations
  • Tohoku University Hospital Sendai, Aoba-ku, Japan
  • Yokohama Municipal Citizen's Hospital Yokohama, Hodogaya-ku, Japan
  • Hospital of Hyogo College of Medicine Hyōgo, Nishinomiya, Japan
  • Osaka University Hospital, Department of Gastroenterological Surgery Osaka, Suita, Japan
View Trial Details
Completed

Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome

NCT00081458

Conditions
Digestive System Diseases, Gastrointestinal Diseases, Hyperphagia, +8 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • Emory University Hospital Atlanta, Georgia, United States
  • Northwestern Center for Clinical Research Chicago, Illinois, United States
View all 32 locations
View Trial Details
Completed

Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) Subjects

NCT00798967

Conditions
Digestive System Diseases, Gastrointestinal Diseases, Hyperphagia, +8 more
Locations
  • Scripps Clinic & Research Foundation La Jolla, California, United States
  • Washington Hospital Center Washington D.C., District of Columbia, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
View all 35 locations
View Trial Details
Completed

Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)

NCT00172185

Conditions
Digestive System Diseases, Gastrointestinal Diseases, Hyperphagia, +8 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Emory University Hospital Atlanta, Georgia, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Albany Medical Center Albany, New York, United States
View all 21 locations
View Trial Details
Completed

Safety, Efficacy and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel Syndrome

NCT03571516

Conditions
Digestive System Diseases, Gastrointestinal Diseases, Intestinal Diseases, +5 more
Locations
  • Helsingin yliopistollinen keskussairaala Helsinki, Finland
  • Groupe Hospitalier Pellegrin - Hôpital des Enfants Bordeaux, Gironde, France
  • Hopital Jeanne de Flandre - CHRU Lille Lille, Nord, France
  • Ospedale Pediatrico Bambino Gesù Roma, Italy
View Trial Details

Related conditions